https://www.urologytimes.com/view/fda-updates-in-urology-may-20262026-06-03T18:15:00Z2026-06-03T18:15:00Z https://www.urologytimes.com/view/comparing-perioperative-strategies-in-cisplatin-eligible-mibc2026-06-03T17:00:00Z2026-06-03T17:00:00Z https://www.urologytimes.com/view/perioperative-therapy-expansion-in-cisplatin-ineligible-mibc2026-06-03T16:55:00Z2026-06-03T16:55:00Z https://www.urologytimes.com/view/fda-approves-titan-prime-inflatable-penile-prosthesis2026-06-03T15:50:00Z2026-06-03T15:50:00Z https://www.urologytimes.com/view/pearls-perspectives-expanding-options-for-men-with-erectile-dysfunction-with-tom-riester2026-06-03T13:00:00Z2026-06-03T13:00:00Z https://www.urologytimes.com/view/how-a-post-rp-mmai-model-performed-in-a-long-term-survivor-population2026-06-03T12:00:00Z2026-06-03T12:00:00Z https://www.urologytimes.com/view/pedro-barata-md-phase-3-data-177lu-rosopatamab-mcrpc2026-06-02T14:45:00Z2026-06-02T14:45:00Z https://www.urologytimes.com/view/phase-1-action-trial-establishes-rp2d-for-225ac-psma-6172026-06-02T12:58:56.711Z2026-06-02T12:58:56.711Z https://www.urologytimes.com/view/tanya-b-dorff-md-highlights-early-data-abbv-969-mcrpc2026-06-01T21:05:07.490Z2026-06-01T21:05:07.490Z https://www.urologytimes.com/view/hrqol-is-preserved-with-perioperative-ev-plus-pembrolizumab-in-mibc2026-06-01T17:40:18.875Z2026-06-01T17:40:18.875Z https://www.urologytimes.com/view/kim-chi-md-sequencing-177lu-psma-617-and-docetaxel-mcrpc2026-06-01T15:30:00Z2026-06-01T15:30:00Z https://www.urologytimes.com/view/fda-approves-cefepime-and-zidebactam-for-complicated-uti2026-06-01T14:21:23.776Z2026-06-01T14:21:23.776Z https://www.urologytimes.com/view/clinical-approaches-for-treatment-intensification-in-metastatic-castration-sensitive-prostate-cancer2026-06-01T12:15:00Z2026-06-01T12:15:00Z https://www.urologytimes.com/view/indirect-trial-comparisons-in-metastatic-castration-sensitive-prostate-cancer2026-06-01T12:00:00Z2026-06-01T12:00:00Z https://www.urologytimes.com/view/proteus-apalutamide-plus-adt-before-and-after-rp-cuts-metastasis-risk2026-05-31T19:00:19.110Z2026-05-31T19:00:19.110Z https://www.urologytimes.com/view/lucia-nappi-md-mir371-early-stage-testicular-cancer2026-05-31T17:30:00Z2026-05-31T17:30:00Z https://www.urologytimes.com/view/ly4052031-shows-early-promise-in-post-ev-urothelial-cancer2026-05-31T15:55:15.497Z2026-05-31T15:55:15.497Z https://www.urologytimes.com/view/adjuvant-pembrolizumab-affects-fatigue-but-not-hrqol-in-muscle-invasive-uc2026-05-31T14:39:15.809Z2026-05-31T14:39:15.809Z https://www.urologytimes.com/view/alicia-morgans-md-discusses-cognitive-effects-darolutamide-vs-enzalutamide-prostate-cancer2026-05-31T14:30:00Z2026-05-31T14:30:00Z https://www.urologytimes.com/view/talapro-3-talazoparib-plus-enzalutamide-improves-rpfs-hrr-gene-altered-mcspc2026-05-31T12:00:00Z2026-05-31T12:00:00Z https://www.urologytimes.com/view/enzalutamide-associated-with-greater-cognitive-decline-than-darolutamide-in-advanced-prostate-cancer2026-05-30T22:45:00Z2026-05-30T22:45:00Z https://www.urologytimes.com/view/enzamet-decipher-score-may-refine-triplet-therapy-use-in-mhspc2026-05-30T22:00:00Z2026-05-30T22:00:00Z https://www.urologytimes.com/view/rana-mckay-md-on-radium-223-plus-cabozantinib-in-renal-cell-carcinoma2026-05-30T20:50:32.169Z2026-05-30T20:50:32.169Z https://www.urologytimes.com/view/ev-p-maintains-os-benefit-at-3-5-years-in-metastatic-uc2026-05-30T19:15:00Z2026-05-30T19:15:00Z https://www.urologytimes.com/view/sakk-06-19-rbcg-added-to-chemo-io-achieves-high-pcr-in-mibc2026-05-30T17:34:49.316Z2026-05-30T17:34:49.316Z https://www.urologytimes.com/view/mark-fleming-md-and-manojkumar-bupathi-md-most-anticipated-gu-data-at-asco-20262026-05-30T17:30:00Z2026-05-30T17:30:00Z https://www.urologytimes.com/view/updated-ev-302-analysis-continues-to-support-ev-p-for-locally-advanced-metastatic-urothelial-carcinoma2026-05-30T13:00:00Z2026-05-30T13:00:00Z https://www.urologytimes.com/view/exome-based-ctdna-shows-low-sensitivity-for-recurrence-detection-in-adjuvant-ccrcc2026-05-29T21:30:00Z2026-05-29T21:30:00Z https://www.urologytimes.com/view/no-sse-fs-benefit-is-observed-with-radium-223-plus-cabozantinib-in-renal-cell-carcinoma2026-05-29T20:27:44.866Z2026-05-29T20:27:44.866Z https://www.urologytimes.com/view/objective-performance-indicators-bring-data-driven-feedback-to-robotic-surgery2026-05-29T15:39:39.398Z2026-05-29T15:39:39.398Z https://www.urologytimes.com/view/break-wave-lithotripsy-achieves-non-inferiority-to-shock-wave-in-pivotal-trial2026-05-29T13:29:00Z2026-05-29T13:29:00Z https://www.urologytimes.com/view/money-matters-how-can-you-plan-for-your-retirement-income-needs-2026-05-29T12:04:52.434Z2026-05-29T12:04:52.434Z https://www.urologytimes.com/view/fda-approves-durvalumab-plus-bcg-for-bcg-naive-high-risk-nmibc2026-05-28T17:30:00Z2026-05-28T17:30:00Z https://www.urologytimes.com/view/bilal-chughtai-md-discusses-cystoscopic-outcomes-with-the-zenflow-spring-system2026-05-28T12:00:00Z2026-05-28T12:00:00Z https://www.urologytimes.com/view/the-evolution-of-reconstructive-urology-with-daniel-eun-md2026-05-27T18:30:00Z2026-05-27T18:30:00Z https://www.urologytimes.com/view/the-emerging-perioperative-era-in-mibc-with-the-niagara-trial2026-05-27T16:50:00Z2026-05-27T16:50:00Z https://www.urologytimes.com/view/the-evolving-treatment-landscape-in-mibc2026-05-27T16:45:00Z2026-05-27T16:45:00Z https://www.urologytimes.com/view/keith-xavier-md-highlights-uui-outcomes-with-itnm-across-care-settings2026-05-27T14:00:00Z2026-05-27T14:00:00Z https://www.urologytimes.com/view/evaluation-of-a-post-rp-mmai-model-design-and-cohort2026-05-27T12:00:00Z2026-05-27T12:00:00Z https://www.urologytimes.com/view/pearls-perspectives-understanding-the-peptide-movement-in-men-s-health-with-larry-lipschultz-md2026-05-26T19:32:53.943Z2026-05-26T19:32:53.943Z https://www.urologytimes.com/view/why-rag-based-ai-models-may-be-more-sufficient-for-patient-education2026-05-26T16:35:53.227Z2026-05-26T16:35:53.227Z https://www.urologytimes.com/view/looking-ahead-where-the-bph-space-is-going2026-05-26T12:00:00Z2026-05-26T12:00:00Z https://www.urologytimes.com/view/the-rationale-for-testing-darolutamide-in-the-mhspc-space2026-05-26T04:00:00Z2026-05-26T04:00:00Z https://www.urologytimes.com/view/from-washington-to-rhode-island-understanding-new-requirements-for-medical-group-governance2026-05-25T14:10:00Z2026-05-25T14:10:00Z https://www.urologytimes.com/view/the-uroonc-minute-focal-therapy-for-prostate-cancer-with-hashim-u-ahmed-bm-bch-oxon-2026-05-25T12:00:00Z2026-05-25T12:00:00Z https://www.urologytimes.com/view/chmp-recommends-approval-of-ev-pembrolizumab-for-cisplatin-ineligible-mibc2026-05-22T16:30:00Z2026-05-22T16:30:00Z https://www.urologytimes.com/view/mark-tyson-md-highlights-additional-safety-data-on-durvalumab-plus-bcg-in-bcg-naive-nmibc2026-05-22T14:20:00Z2026-05-22T14:20:00Z https://www.urologytimes.com/view/urocross-expander-demonstrates-sustained-luts-improvement-through-24-months-in-pivotal-bph-trial2026-05-21T18:05:00Z2026-05-21T18:05:00Z https://www.urologytimes.com/view/mark-garzotto-md-discusses-phase-3-data-on-aglatimagene-in-localized-prostate-cancer2026-05-21T14:50:00Z2026-05-21T14:50:00Z https://www.urologytimes.com/view/how-sexual-interest-shapes-post-treatment-bother-in-localized-prostate-cancer2026-05-20T20:57:24.385Z2026-05-20T20:57:24.385Z https://www.urologytimes.com/view/sarah-psutka-md-on-the-importance-of-frailty-assessment-in-urologic-oncology2026-05-20T17:30:00Z2026-05-20T17:30:00Z https://www.urologytimes.com/view/fda-grants-breakthrough-device-designation-to-vesta-bladder-risk-stratify-dx2026-05-20T15:31:27.038Z2026-05-20T15:31:27.038Z https://www.urologytimes.com/view/fda-to-review-sbla-for-nogapendekin-alfa-inbakicept-for-bcg-unresponsive-papillary-nmibc2026-05-20T13:15:32.609Z2026-05-20T13:15:32.609Z https://www.urologytimes.com/view/setting-the-stage-ai-prognostication-after-radical-prostatectomy2026-05-20T12:00:00Z2026-05-20T12:00:00Z https://www.urologytimes.com/view/pembrolizumab-plus-bcg-elicits-high-cr-rate-in-bcg-na-ve-very-high-risk-t1-nmibc2026-05-19T19:35:53.249Z2026-05-19T19:35:53.249Z https://www.urologytimes.com/view/rana-r-mckay-md-fasco-details-arasec-findings-in-mhspc2026-05-19T17:35:28.645Z2026-05-19T17:35:28.645Z https://www.urologytimes.com/view/real-world-darol-data-support-darolutamide-use-regardless-of-comorbidity-burden2026-05-19T16:45:59.342Z2026-05-19T16:45:59.342Z https://www.urologytimes.com/view/considerations-and-best-practices-when-using-the-prostatic-urethral-lift2026-05-19T12:00:00Z2026-05-19T12:00:00Z https://www.urologytimes.com/view/enzalutamide-plus-leuprolide-yields-longest-treatment-break-in-embark-analysis2026-05-18T16:06:21.874Z2026-05-18T16:06:21.874Z https://www.urologytimes.com/view/phase-1-2-trial-evaluates-recombinant-bcg-in-bcg-na-ve-nmibc2026-05-18T12:00:00Z2026-05-18T12:00:00Z https://www.urologytimes.com/view/break-wave-lithotripsy-meets-both-co-primary-end-points-in-sound-trial2026-05-18T11:08:47.652Z2026-05-18T11:08:47.652Z https://www.urologytimes.com/view/triple-therapy-and-treatment-sequencing-in-mhspc-what-arasec-adds-to-the-conversation2026-05-18T03:10:24.697Z2026-05-18T03:10:24.697Z https://www.urologytimes.com/view/urology-workforce-stable-but-facing-access-and-pipeline-challenges-aua-census-finds2026-05-17T18:28:37.283Z2026-05-17T18:28:37.283Z https://www.urologytimes.com/view/implantable-tibial-nerve-stimulation-outperforms-sham-in-intibia-pivotal-trial2026-05-17T17:30:00Z2026-05-17T17:30:00Z https://www.urologytimes.com/view/detalimogene-voraplasmid-shows-promising-activity-in-bcg-unresponsive-nmibc2026-05-17T16:14:04.981Z2026-05-17T16:14:04.981Z https://www.urologytimes.com/view/chad-reichard-md-on-re-induction-with-nadofaragene-in-nmibc2026-05-17T13:30:00Z2026-05-17T13:30:00Z https://www.urologytimes.com/view/phase-2-arasec-data-add-us-population-evidence-for-darolutamide-in-mhspc2026-05-16T20:21:23.083Z2026-05-16T20:21:23.083Z https://www.urologytimes.com/view/aglatimagene-plus-radiotherapy-improves-prostate-cancer-specific-dfs2026-05-16T18:19:43.654Z2026-05-16T18:19:43.654Z https://www.urologytimes.com/view/phenotype-guided-management-is-key-to-treating-nocturia-in-older-patients2026-05-16T17:51:57.387Z2026-05-16T17:51:57.387Z https://www.urologytimes.com/view/community-engagement-drives-unc-s-effort-to-close-prostate-cancer-care-gaps2026-05-16T13:56:49.791Z2026-05-16T13:56:49.791Z https://www.urologytimes.com/view/the-uroonc-minute-cystectomy-vs-bladder-sparing-therapy-with-mary-beth-westerman-md-facs2026-05-16T12:00:00Z2026-05-16T12:00:00Z https://www.urologytimes.com/view/aua-2026-expanded-potomac-analyses-support-durvalumab-plus-bcg2026-05-15T22:32:08.847Z2026-05-15T22:32:08.847Z https://www.urologytimes.com/view/arasec-darolutamide-plus-adt-reduces-progression-risk-in-mhspc2026-05-15T20:34:04.579Z2026-05-15T20:34:04.579Z https://www.urologytimes.com/view/fda-approves-atezolizumab-as-adjuvant-therapy-for-mibc-guided-by-ctdna2026-05-15T19:03:22.648Z2026-05-15T19:03:22.648Z https://www.urologytimes.com/view/perioperative-durvalumab-plus-enfortumab-vedotin-improves-efs-in-cisplatin-ineligible-mibc2026-05-14T14:05:00Z2026-05-14T14:05:00Z https://www.urologytimes.com/view/pearls-perspectives-rethinking-pelvic-pain-and-bladder-health-with-heather-florio2026-05-14T14:00:00Z2026-05-14T14:00:00Z https://www.urologytimes.com/view/study-psadt-is-often-undocumented-in-high-risk-biochemical-recurrence2026-05-14T12:00:00Z2026-05-14T12:00:00Z https://www.urologytimes.com/view/aua-2026-preview-practice-changing-trials-in-benign-urology2026-05-13T16:35:39.927Z2026-05-13T16:35:39.927Z https://www.urologytimes.com/view/fda-grants-clearance-to-total-testosterone-assay2026-05-13T14:32:08.083Z2026-05-13T14:32:08.083Z https://www.urologytimes.com/view/savitha-krishnan-md-discusses-patient-selection-for-robotic-sacrocolpopexy2026-05-13T14:22:14.506Z2026-05-13T14:22:14.506Z https://www.urologytimes.com/view/aua-2026-preview-practice-changing-trials-in-urologic-oncology2026-05-12T20:06:58.345Z2026-05-12T20:06:58.345Z https://www.urologytimes.com/view/matthew-nielsen-md-ms-facs-previews-key-themes-at-the-2026-aua-annual-meeting2026-05-12T17:27:41.974Z2026-05-12T17:27:41.974Z https://www.urologytimes.com/view/isaac-kim-md-on-advances-driving-the-future-of-prostate-cancer-outcomes2026-05-12T16:30:00Z2026-05-12T16:30:00Z https://www.urologytimes.com/view/decision-making-for-bph-in-the-mists-era2026-05-12T12:00:00Z2026-05-12T12:00:00Z https://www.urologytimes.com/view/resident-perspective-yeonsoo-sara-lee-md-discusses-top-priorities-at-aua-20262026-05-11T19:30:24.054Z2026-05-11T19:30:24.054Z https://www.urologytimes.com/view/edison-histotripsy-system-submitted-to-fda-for-kidney-tumor-indication2026-05-11T17:45:00Z2026-05-11T17:45:00Z https://www.urologytimes.com/view/fda-grants-de-novo-authorization-to-aurie-reusable-intermittent-catheter-system2026-05-11T14:40:00Z2026-05-11T14:40:00Z https://www.urologytimes.com/view/expanding-access-to-bladder-cancer-detection-tools2026-05-08T18:20:00Z2026-05-08T18:20:00Z https://www.urologytimes.com/view/reassessing-cis-in-bcg-unresponsive-disease2026-05-08T18:15:00Z2026-05-08T18:15:00Z https://www.urologytimes.com/view/cis-detection-shared-responsibility-in-nmibc-care2026-05-08T17:40:00Z2026-05-08T17:40:00Z https://www.urologytimes.com/view/why-cis-reporting-matters-in-bladder-cancer-care2026-05-08T17:20:00Z2026-05-08T17:20:00Z https://www.urologytimes.com/view/the-uroonc-minute-emergency-hematuria-management-with-nikita-r-bhatt-mbbs-mch-mmed-frcs2026-05-08T10:00:00Z2026-05-08T10:00:00Z https://www.urologytimes.com/view/fda-clears-glean-abdominal-sensor-expanding-catheter-free-urodynamics-platform2026-05-07T15:40:00Z2026-05-07T15:40:00Z https://www.urologytimes.com/view/precision-escalation-may-define-the-future-of-high-risk-nmibc-care2026-05-07T14:20:00Z2026-05-07T14:20:00Z https://www.urologytimes.com/view/integrating-evidence-and-identifying-future-research-needs-in-metastatic-castration-sensitive-prostate-cancer-mcspc-2026-05-07T12:05:00Z2026-05-07T12:05:00Z https://www.urologytimes.com/view/evaluating-observational-and-propensity-matched-studies-in-metastatic-castration-sensitive-prostate-cancer-mcspc-2026-05-07T12:00:00Z2026-05-07T12:00:00Z https://www.urologytimes.com/view/charles-powell-md-highlights-neuspera-system-s-12-month-uui-outcomes2026-05-06T18:50:00Z2026-05-06T18:50:00Z https://www.urologytimes.com/view/bladder-cancer-awareness-month-the-rise-of-biomarkers-and-precision-care2026-05-06T16:50:02.824Z2026-05-06T16:50:02.824Z https://www.urologytimes.com/view/mps2-as-outperforms-mpmri-for-prostate-cancer-upgrading-during-active-surveillance2026-05-06T14:45:50.852Z2026-05-06T14:45:50.852Z https://www.urologytimes.com/view/integrating-psma-pet-into-clinical-practice-in-advanced-prostate-cancer2026-05-06T13:27:35.789Z2026-05-06T13:27:35.789Z